Jump to content

Ortho Panel Cells -Quality Assurance


ffriesen

Recommended Posts

14 hours ago, pinktoptube said:

Why can't they just be treated like the screening cells? Run a positive and negative control day (same that you use for the screen) of use.

Are you suggesting that one tests every panel cell every day of use ?

Link to comment
Share on other sites

16 hours ago, Christy Spence said:

We use 1:9 dilution of QC antisera (anti-D & anti-c) upon arrival / prior to use. "Periodically" and "weak antibodies" are way too vague...

Again, continuing my earlier thread: Rh antigens are very stable and may not be representative of deterioration of other antigens.

Link to comment
Share on other sites

3 hours ago, Ensis01 said:

I'm not trying to be funny; but if Ortho requires the lab to QC the panel periodically why do the panels have an expiry date. I mean it has been pointed out in several threads that the manufacturers QC and stability testing and requirements must far exceed what a lab could do or be expected to do. Am I missing something?

An interesting twist ! One could look at it that way.

Red cell products ultimately do deteriorate and that's why they must have an expiration date. Hemolysis is often the first visual clue. However, that doesn't mean that all of the antigens have suddenly become unrecognizable; it just means some of the older cells in the vial have popped. Studies have been published demonstrating that antigens remain stable many days/weeks after official expiration.

Manufacturers do have oodles of stability data - both static (in-house) and following shipping. Typically a unit of red cells that is turned into a red cell product has at least an eight-week expiration. This allows for manufacturing and shipping to the end users who then usually have five-weeks left on the expiration. In reality, those expiration dates could be longer, but the manufacturers deliberately give themselves a buffer period, just in case.

The wildcard in this whole process and issue upon which the regulatory agencies focus is shipping. How do the end users know that something horrible didn't happen to the material ? An unanswerable question. Even though the manufacturers have shipping stability data, they can't possibly foresee and test every odd, weird situation. One could argue that Ortho have less faith in their shipping process than other suppliers, hence the requirement for periodic QC.

Link to comment
Share on other sites

We've written our policy to state that we run a "positive" cell on each panel we run each day.  For example, if we have Fya patient, then we run the patient sample on a FYa positive cell on each rule out panel run.  This way we are testing stability of panels throughout the life of each panel.  In addition, we are testing different antigens throughout the week because we are a large facility with lots of antibody identifications being done.   I know it seems a bit of a simple interpretation of the rule.  We are currently in our CAP inspection window, so hopefully this is acceptable to our next inspector. 

Link to comment
Share on other sites

On ‎3‎/‎9‎/‎2017 at 6:20 AM, mollyredone said:

What we do is use the current cells for our QC for our antigen typing, using a heterozygous cell as a positive control for whatever antigen we are testing.  That seems periodic to me.

This covers 3% panel cells, but what about any 0.8% panels? We currently have 7 indated 0.8% panels and three 3% indated panels. We had to add additional panels to our standing order since we can no longer use out-dated panel cells! :(

Link to comment
Share on other sites

1 hour ago, lehooke1 said:

 

On 3/9/2017 at 6:20 AM, mollyredone said:

What we do is use the current cells for our QC for our antigen typing, using a heterozygous cell as a positive control for whatever antigen we are testing.  That seems periodic to me.

This covers 3% panel cells, but what about any 0.8% panels? We currently have 7 indated 0.8% panels and three 3% indated panels. We had to add additional panels to our standing order since we can no longer use out-dated panel cells!

 

Do you perform all your antigen typing in tubes?  We validated our Fya and Fyb in gel, so that is what we use for antigen typing and QC'ing the 0.8% panel cells.

Link to comment
Share on other sites

15 hours ago, Eagle Eye said:

we select Fya neg and Fya double dose cell to run with the dilution...to meet package insert requirement....

 

Apologies in advance, I don't have Ortho package inserts handy. Does the insert actually suggest using an Fy(a+b-) panel cell?

Edited by exlimey
Clarification
Link to comment
Share on other sites

On 3/9/2017 at 2:07 PM, exlimey said:

Unfortunately, I'm not surprised. I would consider myself lucky to get an inspector who even knows blood groups.

I always wonder whether the CV of test would qualify as the test for element of uncertainty.  We do not have that in USA.  I've asked aeround and no ones seems to even know what I am talking about.

Link to comment
Share on other sites

2 hours ago, exlimey said:

Don't do any. I use panels, but I don't work in a clinical laboratory.

You wouldn't get away with that now in the UK.  The accrediting people have got more and more severe, and would quite happily take your legs off at the knees now (figuratively speaking)!

Link to comment
Share on other sites

1 hour ago, Malcolm Needs said:

You wouldn't get away with that now in the UK.  The accrediting people have got more and more severe, and would quite happily take your legs off at the knees now (figuratively speaking)!

Perhaps some clarification is in order. I'm in the US but am not subject to the clinical regulations that apply to hospitals and blood centers that do clinical work on patients (or donors). Those regulations, often with the addition of local/state riders, are "enforced" by a number of government entities and surrogates.

My facility is not "accredited" by any agency, but instead we are licensed by the FDA for the specific work that we do. The FDA inspect us (as well as our internal auditors) using a completely different set of criteria.

Link to comment
Share on other sites

Without getting into the details, we were told by a CAP 'inspector' that we must run QC on the panel, that using the QC results from our Antigen Typing QC doesn't count.  So, we started running the full panel with reagent QC Antisera upon receipt.  n.b. The 'Lab General' section of CAP, which BB is bound to as well, states that QC must be done on EVERY reagent upon receipt.

THEN, two years later for the next CAP, the 'inspector' tells us to 'stop this, it is non-sense!'.  *^&%)W%*

We didn't ... because of that 'Lab General' rule.

After reading all your replies and ideas, I think I'm going to revise our 'QC' to testing a few cells (rather than all of them) with diluted antisera, Fya+b- and Fya-b-, including the Ficin panel. 

Keep talking ... we need a 'standard' thought about this!

Link to comment
Share on other sites

I called CAP about this subject about 2 years ago (Specifically- TRM.31250 and COM.30450)

1. I was told first to follow manufacturer's package insert. We use Immucor and my way of thinking, MAY do QC doesn't mean HAVE TO. I could argue with an inspector.

2. I asked what should we do to a new set of panel cells to meet CAP standards. I was told you must document visual inspection of shipping conditions. Did the panels arrive under cool conditions, was the shipping container damaged, do they appear hemolyzed, etc. No other QC must be performed before use. Since we use these panels as pos and neg controls through out the life of the panel, this can be used as QC. I had a form of incoming reagents, I added a column to address shipping conditions as acceptable or unacceptable with a blip at the bottom about what is acceptable or not to cover my bases. I added a column to my Ag typing form to add the panel # used for positive and negative controls.

3. I asked about QC on expired panel cells. These are considered as rare and only used for complicated ID. Use in-date first and only use expired if in-date panels are not sufficient. No QC is required on expired panels, however the panel cell must be acceptable (not hemolyzed). I was sited for using expired panels 2 CAPs ago and it was expunged.

4.I also asked about IQCP on panels on same call just to make sure. NO IQCP is necessary. (This was back when IQCP was new and nobody knew what was going on)

She stated that all of this had to be written in your policies and procedures and there must be documentation of being done. She said the difference is antibody detection and antibody identification. Detection systems (screening cells) must have QC done on day of use. Antibody identification (panels) are different and do not require the same level of QC. It sounded very reasonable.  

I called a different time and asked about comparison of new lot numbers specifically of all antisera. I was told then that we did not have to compare old lot numbers to new lot numbers because we do QC on each day of use. The QC must pass or the antisera can't be used. Again documentation. You didn't do it if you didn't write it down.

 

Link to comment
Share on other sites

i cannot remember we do in-dated panel cells QC in the reference lab use antiserum . Just as Debbiel mentioned the panel cells must be visually qualified.

we use them to do antibodies identification, then get the result, use reagent antiserum to confirm the antigen is absence on the auto cells if DAT is neg( if we have those reagent), then use two antigen pos cells and two antigen neg cells to confirm the antibodies again.

the panel cells express a lot of antigens , some of them are rare and it is hard to get the specific antiserum, i think it is hard to QC those antigens during the life span of the panel.

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.
  • Advertisement

×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.